Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer
Clinical trial NCT01560663 · UNKNOWN
Trial details
- NCT number
- NCT01560663
- Sponsor
- Miguel Martín Jiménez
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2012-01-01
- Primary completion
- 2023-12-01
- Enrollment
- 415
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.